UBS Cuts KOSPI Target to 2,500 for Second Time, Pressured by FX and Earnings
nashnova research
UBS cut its 12-month KOSPI target to 7,500 for the second time in two months, driven by a ~15% won appreciation that is squeezing corporate earnings — and market consensus has yet to fully price in the hit.
Two cuts in two months — what is UBS worried about?
On October 29 UBS lowered its KOSPI 12-month target from 8,000 to 7,500, a 6% cut, implying a forward P/E of just 6×.
On September 18 analyst Yong-Suk Son had already cut the target from 8,800 to 8,000 — nearly 10%. This means → the cumulative reduction over two months is close to 15%, a clear signal that UBS thinks earnings expectations still have further to fall.
The core driver is a double squeeze: won appreciation compressing export profits + bottom-up EPS forecasts being revised down.
How does a stronger won hurt the stock market?
The Korean won has appreciated ~15% since June. In plain terms = Korean companies earn much of their revenue overseas in foreign currencies; a stronger won means the same offshore income converts into fewer won, shrinking profits.
UBS estimates FX alone will drag 2026 KOSPI EPS down by ~2% and 2027 EPS by ~10%.
October's consensus EPS monthly revision was only -0.5% — far from enough. This means → analysts have not yet priced in the full won-appreciation shock, and further downgrades are likely ahead.
After a 10% pullback, how much more downside is there?
KOSPI has already fallen ~10% from its peak, approaching UBS's downside value zone of 5,000 (4× P/E).
The KOSPI 200 put/call ratio — a gauge of market fear — has hit negative one standard deviation, a level that historically signals oversold conditions. This means → risk aversion is already extreme; unless earnings deteriorate further or an external shock hits, additional downside is limited.
UBS sets its upside target at 9,300 (8× P/E). In plain terms = UBS sees KOSPI oscillating in a 5,000–9,300 range, with the 7,500 target sitting in neutral-to-cautious territory.
Where do valuations and fund flows stand now?
KOSPI trades at 1.1× NTM price-to-book — a measure of valuation based on the next twelve months' net assets — in line with its historical average. Dividend yield is 2.7%, one standard deviation above the mean — relatively high.
Strip out Samsung Electronics and SK Hynix, and the rest of KOSPI trades at just 0.9× P/B and 6.6× P/E, both well below historical norms. This reflects a market where the "expensive" tag belongs almost entirely to two semiconductor giants; everything else is already cheap.
On the flow side, foreign investors have net-sold KRW 19.0 billion since October — the biggest source of selling pressure — partially offset by corporate buybacks (KRW 9.9 billion), retail (KRW 5.8 billion), and local institutions (KRW 3.2 billion). Foreign net-selling has recently narrowed and even flipped to net-buying this week.
Which sectors got hit hardest, and which could lead a recovery?
The steepest earnings downgrades hit chemicals, entertainment, defense, autos, consumer discretionary, diversified financials, internet, and cosmetics — spanning both export and domestic demand, showing the breadth of the won-appreciation impact.
Sectors with relative upgrades: energy, transport, construction, and insurance — mostly domestic or resource-oriented, with less FX drag.
UBS forecasts 2026 KOSPI EPS growth of +258% (consensus: +278%) and 2027 growth of +33% (consensus: +38%) — more conservative than the street. Tech remains the biggest 2026 growth contributor; battery materials, utilities, and chemicals are expected to take the lead in 2027.
What is the key signpost before year-end?
UBS is explicit: this round of EPS cuts is an FX-driven "reset," not the start of a sustained earnings downcycle.
KOSPI will remain under pressure into year-end. The key signpost is whether consensus EPS completes its full adjustment for won appreciation. In plain terms = once analysts finish repricing the FX hit and earnings forecasts settle, the market nears a floor; if the adjustment drags on, the overhang persists.
SK Hynix's restart of its buyback program could provide near-term support — one of the few positive catalysts in sight.
市场有风险，内容仅供研究参考，不构成投资建议。